T2	binds-constituent1 499 503	Gab1
T3	binds-constituent2 509 514	c-Met
T4	binds-catalysis 518 527	abrogated
T5	binds-controller 531 558	the MBS mutation (Δc-Met), 
T9	binds-constituent2 643 648	c-Met
T10	m-val 665 712	a reduced strength compared with wild-type Gab1
T14	binds-constituent1 714 718	Grb2
T15	binds-constituent2 736 740	Gab1
T16	binds-catalysis 745 757	not affected
T17	binds-controller 761 799	the V490A mutation in the MBS (Δc-Met)
T18	binds-catalysis 805 814	impaired 
T19	binds-controller 817 863	mutation of the two Grb2-binding sites (ΔGrb2)
T20	binds-controller 30 34	Grb2
T21	binds-complex 39 49	Gab1-c-Met
T22	process 87 115	immunoprecipitation analyses
T23	cell-type 152 185	293 human kidney epithelial cells
T24	process 191 202	transfected
T25	transfection-molecule 235 259	Flag epitope-tagged Gab1
T26	transfection-molecule 273 295	HA epitope-tagged Grb2
T27	process 303 314	stimulation
T28	incubation-reagent 340 346	HGF/SF
T29	transfection-molecule 318 334	endogenous c-Met
T30	ip-molecule 348 352	Gab1
T31	coreference-target 357 376	its mutant proteins
T32	process 382 394	precipitated
T33	ip-molecule 400 409	anti-Flag
T34	process 454 470	Western blotting
T1	binds-constituent1 564 627	the Gab1 mutant which lacks both Grb2 association sites (ΔGrb2)
T6	binds-constituent1 920 924	Gab1
T7	binds-constituent1 930 935	c-Met
T8	binds-controller 947 977	direct interaction via its MBS
T11	binds-controller 985 989	Grb2
T12	binds-catalysis 1002 1021	add to the strength
